» Articles » PMID: 35574338

Transfer RNA-Derived Small RNAs: Novel Regulators and Biomarkers of Cancers

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 May 16
PMID 35574338
Authors
Affiliations
Soon will be listed here.
Abstract

Transfer RNA-derived small RNAs (tsRNAs) are conventional non-coding RNAs (ncRNAs) with a length between18 and 40 nucleotides (nt) playing a crucial role in treating various human diseases including tumours. Nowadays, with the use of high-throughput sequencing technologies, it has been proven that certain tsRNAs are dysregulated in multiple tumour tissues as well as in the blood serum of cancer patients. Meanwhile, data retrieved from the literature show that tsRNAs are correlated with the regulation of the hallmarks of cancer, modification of tumour microenvironment, and modulation of drug resistance. On the other side, the emerging role of tsRNAs as biomarkers for cancer diagnosis and prognosis is promising. In this review, we focus on the specific characteristics and biological functions of tsRNAs with a focus on their impact on various tumours and discuss the possibility of tsRNAs as novel potential biomarkers for cancer diagnosis and prognosis.

Citing Articles

The role of tRNA-Derived small RNAs (tsRNAs) in pancreatic cancer and acute pancreatitis.

Pan Y, Ying X, Zhang X, Jiang H, Yan J, Duan S Noncoding RNA Res. 2025; 11:200-208.

PMID: 39896345 PMC: 11786804. DOI: 10.1016/j.ncrna.2024.12.011.


Dysregulated transfer RNA-derived small RNAs as potential gastric cancer biomarkers.

Yuan J, Gu W, Xu T, Zhang Y, Shen L, Yan J Exp Biol Med (Maywood). 2024; 249:10170.

PMID: 39735780 PMC: 11673218. DOI: 10.3389/ebm.2024.10170.


Identification of serum tsRNA-Thr-5-0015 and combined with AFP and PIVKA-II as novel biomarkers for hepatocellular carcinoma.

Jin K, Wu J, Yang J, Chen B, Xu J, Bao H Sci Rep. 2024; 14(1):28834.

PMID: 39572775 PMC: 11582641. DOI: 10.1038/s41598-024-80592-y.


tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB.

Xu R, Du A, Deng X, Du W, Zhang K, Li J J Exp Clin Cancer Res. 2024; 43(1):230.

PMID: 39153969 PMC: 11330149. DOI: 10.1186/s13046-024-03132-6.


Transfer RNA‑derived small RNAs: A class of potential biomarkers in multiple cancers (Review).

Mao C, Yuan W, Fang R, Wu Y, Zhang Z, Cong H Oncol Lett. 2024; 28(1):293.

PMID: 38737976 PMC: 11082847. DOI: 10.3892/ol.2024.14427.


References
1.
Clara J, Monge C, Yang Y, Takebe N . Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2019; 17(4):204-232. DOI: 10.1038/s41571-019-0293-2. View

2.
Qin C, Xu P, Zhang X, Zhang C, Liu C, Yang D . Pathological significance of tRNA-derived small RNAs in neurological disorders. Neural Regen Res. 2019; 15(2):212-221. PMC: 6905339. DOI: 10.4103/1673-5374.265560. View

3.
Xue M, Shi M, Xie J, Zhang J, Jiang L, Deng X . Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for pancreatic ductal adenocarcinoma. Am J Cancer Res. 2021; 11(3):837-848. PMC: 7994152. View

4.
Goodarzi H, Liu X, Nguyen H, Zhang S, Fish L, Tavazoie S . Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement. Cell. 2015; 161(4):790-802. PMC: 4457382. DOI: 10.1016/j.cell.2015.02.053. View

5.
Zong T, Yang Y, Zhao H, Li L, Liu M, Fu X . tsRNAs: Novel small molecules from cell function and regulatory mechanism to therapeutic targets. Cell Prolif. 2021; 54(3):e12977. PMC: 7941233. DOI: 10.1111/cpr.12977. View